FREEDOM COVID-19 Anticoagulation Strategy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anu Lala, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Valentin Fuster, MD,PhD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Prevent Senior - Ips
São Paulo, Brazil
- Instituto Do Coração - Incor
São Paulo, Brazil
- Clínica de la Costa
Barranquilla, Colombia
- Clínica Shaio
Bogotá, Colombia
- Fundación Cardioinfantil
Bogotá, Colombia
- Fundacion Oftalmológica de Santander - Foscal
Bucaramanga, Colombia
- Centro Médico Imbanaco
Cali, Colombia
- Cardiovid
Medellín, Colombia
- Eternal Heart Care Centre and Research Ins Pvt Ltd.
Jaipur, India
- Jaipur National University
Jaipur, India
- Sawai Mann Singh Hospital
Jaipur, India
- Jaslok Hospital & Research Center
Mumbai, India
- Saifee Hospital
Mumbai, India
- Sengupta Hospital & Research Institute
Nagpur, India
- D Y Patil University School of Medicine & D Y Patil Hospital
Navi Mumbai, India
- Hospital Cardiológica Aguascalientes
Aguascalientes, Mexico
- Centro Médico Nacional 20 de Noviembre
Mexico City, Mexico
- Christus Muguerza Hospital Alta Especialidad
Monterrey, Mexico
- Centro de Estudios Clinicos de Querétaro S.C.
Querétaro City, Mexico
- Centro Medico Hospital del Prado
Tijuana, Mexico
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Sept 2020
- Primary completion
- 30 Dec 2022
- Completion
- 30 Dec 2022
- Last update posted
- 16 Mar 2023
- Registered enrollment
- 3,460
- Registry id
- NCT04512079
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.